Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 22, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - September 22, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 102     Next >>     Go To Page:

9/15/17 - Advisory Committee; Nonprescription Drugs Advisory Committee, Renewal
SUMMARY: The Food and Drug Administration is announcing the renewal of the Nonprescription Drugs Advisory Committee by the Commissioner of Food and Drugs. SUPPLEMENTARY INFORMATION: Pursuant to 41 CFR 102-3.65 and approval by the Department of Health and Human Services pursuant to 45 CFR part 11 and by the General Services Administration, FDA is an
9/15/17 - Pharmacists play an important role in monitoring, policy making and regulatory affairs - Latif Sheikh
Abdul Latif Sheikh a well known pharmacist and President of Pakistan Health System Pharmacists while highlighting the role of pharmacists in creating health awareness at the Pakistan Pharma Summit-III organized by PPMA at Lahore from July 23-25, 2017. Total Pakistan Pharmaceutical market, he said, was over two Billion US$. Having looked at the webs
9/14/17 - BioPharmX Announces Preliminary Data from Rosacea Feasibility Study
Release date- 13092017- MENLO PARK, Calif.- BioPharmX Corporation, a specialty pharmaceutical company focusing on dermatology, is announcing preliminary data from a feasibility study of BPX-01 to assess the safety and efficacy of topical minocycline gel at both the 1% and 2% doses for the treatment of rosacea. The preliminary data from the ongoing
9/14/17 - House Conducted 11 Committee Hearings Yesterday
The U.S. House of Representatives conducted 11 committee hearings yesterday:. "Modernizing FDA's Regulation of Over-the-Counter Drugs". Testimony was heard from Janet Woodcock, Director, Center for Drug Evaluation and Research, Food and Drug Administration; and public witnesses.
9/14/17 - Innovus Pharma to Present at Rodman & Renshaw 19th Annual Global Investment Conference
By a News Reporter-Staff News Editor at Women's Health Weekly Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, announced that Dr. The corporate...
9/14/17 - Sunovion's Aptiom (eslicarbazepine acetate) Receives FDA Approval for Expanded Indication to Treat Partial-Onset Seizures in Children and Adolescents 4 Years of Age and Older
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration approved the supplemental New Drug Application to expand the indication for its antiepileptic drug Aptiom to include treatment of partial-onset seizures in children and adolescents four to 17 years of age. APTIOM is also approved in the U.S. for the treatmen
9/13/17 - "Modernizing FDA's Regulation of Over-the-Counter Drugs."
FDA regulates most of the drugs on drug store shelves under the "OTC monograph system," though manufacturers do have the option to file a new drug application in lieu of using the OTC monograph system for OTC products. FDA publishes monographs that provide a rulebook for marketing safe and effective products containing particular active ingredients
9/13/17 - BioPharmX Reports Second Quarter 2018 Financial Results
BioPharmX Corporation, a specialty pharmaceutical company focusing on dermatology, today announced its financial results for the second quarter ended July 31, 2017 and discussed the progress of its clinical research. "Momentum that began during our first quarter continues," said BioPharmX President Anja Krammer. During the past month, BioPharmX
9/13/17 - HEALTHCARE - Ascendis has Europe acquisitions in sights
Ascendis Health is eyeing bolt-on acquisitions in Central and Eastern Europe in 2018 to boost its business. The healthcare group bought a number of companies in countries such as Cyprus that lifted its revenue for the year to June. The company had acquired pharmaceutical manufacturer Remedica Holdings in Cyprus and European sports nutrition busines
9/13/17 - House Schedules 11 Committee Hearings for Sept. 13
The U.S. House of Representatives scheduled 11 committee hearings for Sept. 13:. Subcommittee on Workforce Protections; and Subcommittee on Health, Employment, Labor, and Pensions:. "Modernizing FDA's Regulation of Over-the-Counter Drugs".
9/13/17 - PLx Pharma Retains Dr. Efthymios N. Deliargyris as Chief Medical Advisor
PLx Pharma Inc., a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec? 325 mg and Aspertec? 81 mg, today announced the addition of Efthymios N. Deliargyris, MD, FACC, FESC, FSCAI, as Chief Medical Advisor. Deliargyris, an internationally-recognized expert in the field of thrombosis,
9/13/17 - Sanofi and Regeneron Announce Positive Dupilumab Topline Results From Phase 3 Trial in Uncontrolled Persistent Asthma
Release date- 12092017- Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the pivotal Phase 3 LIBERTY ASTHMA QUEST study of dupilumab in a broad population of patients with uncontrolled, persistent asthma met its two primary endpoints. The companies plan to submit a Supplemental Biologics License Application to the U.S. Food and Drug.
9/13/17 - SUNY Canton Announces Upcoming Leadership Lecture Series Presentations
*Myrna Thomas, a 1979 graduate and the vice president for quality assurance and regulatory affairs at Accupac Inc. will be presenting at noon, Thursday, Sept. 14, in the Richard W. Miller Campus Center Room 214. Accupac fills and packages a wide range of over-the-counter and prescription products for the world's largest pharmaceutical companies.
9/12/17 - Array BioPharma - Phase 3 BEACON CRC Safety Lead in Results in BRAF Mutant Colorectal Cancer Presented at European Society for Medical Oncology Congress
Release date- 11092017- BOULDER, Colo.- Array BioPharma and Pierre Fabre today announced safety results and initial clinical activity from the safety lead in of the Phase 3 BEACON CRC study evaluating binimetinib, a MEK inhibitor, encorafenib, a BRAF inhibitor and Erbitux, an anti EGFR antibody, in patients with BRAF mutant colorectal cancer whose
9/12/17 - BioPharmX Announces Preliminary Data from Rosacea Feasibility Study
BioPharmX Corporation, a specialty pharmaceutical company focusing on dermatology, is announcing preliminary data from a feasibility study of BPX-01 to assess the safety and efficacy of topical minocycline gel at both the 1% and 2% doses for the treatment of rosacea. The preliminary data from the ongoing study suggest good tolerability and promis
9/12/17 - Howard Sklamberg Quoted by Bloomberg BNA on FDA's New Drug Facility Inspection Process
Akin Gump health partner Howard Sklamberg has been quoted in the Bloomberg BNA Pharmaceutical Law& Industry Report article "FDA Puts Heads Together to Streamline Drug Facility Inspections," regarding steps being taken by the Food and Drug Administration to improve its oversight of drug manufacturing. The article reports that the FDA's Center for Dr
9/12/17 - Vantage Point: We need technology and transparency
Helenan of a certain age was complaining to me recently about age-related hearing loss and the ridiculously high cost of hearing aids. A couple of government scientific bodies are asking that the FDA allow these devices to be marketed for hearing loss. This has all the characteristics of a classic Washington power struggle: something new and inexpe
9/11/17 - Alvogen Subsidiary Confirms ANDA Filing and Patent Challenge for Generic Revlimid
Alvogen subsidiary, Lotus Pharmaceuticals, today announced that Celgene filed a suit on 6 September 2017 in the United States District Court for the District of New Jersey. The product was developed by Lotus pharmaceuticals in Taiwan. Robert Wessman, Alvogen Chairman and CEO, said, The FDA acceptance of our ANDA filing is an important milestone
9/11/17 - Anti-counterfeit Packaging Market in Pharmaceutical Industry Research by Production,Revenue,Market Manufacturer & Region-in Depth Analysis Report 2017
The report covers the present scenario and the growth prospects of the global anti-counterfeit packaging market in pharmaceutical industry for 2017-2021. To calculate the market size, the report considers the revenue generated by different vendors through the sales of various technologies that include covert technologies and overt technologies. The
9/11/17 - Blue Cross forum addresses high health care costs, drug prices
Blue Cross and Blue Shield of Louisiana president and CEO Dr. Steve Udvarhelyi says the problems with the U.S. health care system he saw as a young doctor endure today. But they have shifted more of the increasing cost to workers, whose premium contributions have increased nearly 80 percent since 2006, according to the Kaiser Family Foundation.
9/11/17 - Patent Application Titled "Topical Anorgasmia Therapy" Published Online (USPTO 20170239175)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors THOMPSON, RONALD J.; Thompson, James M., filed on February 19, 2016, was made available online on August 31, 2017. The assignee for this patent application is FSD
9/11/17 - Patent Issued for Enhanced Stability of Novel Liquid Compositions (USPTO 9744133)
By a News Reporter-Staff News Editor at Pharma Business Week Pfizer Inc. has been issued patent number 9744133, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Agisim, Gary Robert; Friedline, Robert Alan; Patel, Shivangi Akash; Sertzen, Cesar Ivan; Shepperson, Vanessa Rose. This p
9/11/17 - Patent Issued for Method for Treating Hypertension (USPTO 9744165)
By a News Reporter-Staff News Editor at Clinical Trials Week TSH Biopharm Corporation Ltd. has been issued patent number 9744165, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Chen, Jaw-Wen; Wang, Hsi-Chieh; Juang, Shin-Yi. This patent was filed on April 28, 2016 and was publish
9/11/17 - Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Phase 3 Trial in Uncontrolled Persistent Asthma
TARRYTOWN, N.Y. and PARIS, Sept. 11, 2017/ PRNewswire/ Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the pivotal Phase 3 LIBERTY ASTHMA QUEST study of dupilumab in a broad population of patients with uncontrolled, persistent asthma met its two primary endpoints. The companies plan to submit a Supplemental Biologics License Appli
9/11/17 - VANC PHARMACEUTICALS INC - PROVINCIAL FORMULARY APPROVALS FOR ATLANTIC CANADA
Release date- 08092017- VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets, announces that it has received an initial set of provincial formulary approvals for generic products in Atlantic Canada. VANC generic products have been listed in formularies and marketed in six of the large
Articles(s): 1 - 25 of 102     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415